Guía española para el manejo del asma (GEMA) versión 5.1. Aspectos destacados y controversias

Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme

(2020) Bright I. Nwaru et al.   EUROPEAN RESPIRATORY JOURNAL

Eleven faces of coronavirus disease 2019

(2020) Xiang Dong et al.   ALLERGY

FeNO for Asthma Diagnosis in Adults: More Lights Than Shadows

(2020) Iñigo Ojanguren et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)

(2020) Christian Gessner et al.   RESPIRATORY MEDICINE

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

(2020) Huib A M Kerstjens et al.   Lancet Respiratory Medicine

NOVEDADES Y OTROS ASPECTOS DETACADOS DE LA GUIA ESPAÑOLA PARA EL MANEJO DEL ASMA (GEMA), VERSIÓN 5.0

(2020) Vicente Plaza et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak

(2020) Manuel Jorge Rial et al.   Journal of Allergy and Clinical Immunology-In Practice

Clinical factors associated with the overuse of asthma rescue medication

(2019) I Urrutia et al.   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Referral criteria for asthma: Consensus document

(2019) M Blanco Aparicio et al.   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

(2019) Richard Beasley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

(2019) Jo Hardy et al.   LANCET

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials

(2019) Johann Christian Virchow et al.   LANCET

Scottish consensus statement on the role of FeNO in adult asthma

(2019) Chris RuiWen Kuo et al.   RESPIRATORY MEDICINE

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

(2018) Paul M. O’Byrne et al.   NEW ENGLAND JOURNAL OF MEDICINE

As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

(2018) Eric D. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severe eosinophilic asthma: a roadmap to consensus

(2017) Roland Buhl et al.   EUROPEAN RESPIRATORY JOURNAL

The paradoxes of asthma management: time for a new approach?

(2017) Paul M. O'Byrne et al.   EUROPEAN RESPIRATORY JOURNAL

Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control

(2015) William W. Busse et al.   CHEST

A repeated short educational intervention improves asthma control and quality of life

(2015) Vicente Plaza et al.   EUROPEAN RESPIRATORY JOURNAL

T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma

(2009) Prescott G. Woodruff et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A new perspective on concepts of asthma severity and control

(2008) D. R. Taylor et al.   EUROPEAN RESPIRATORY JOURNAL